Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QHB1
Term | Name | Level | Count |
---|---|---|---|
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 10 | 2 |
GO:0000470 | maturation of LSU-rRNA | 9 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006364 | rRNA processing | 8 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016072 | rRNA metabolic process | 7 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.586 |
CLV_NRD_NRD_1 | 250 | 252 | PF00675 | 0.484 |
CLV_NRD_NRD_1 | 261 | 263 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 281 | 283 | PF00675 | 0.333 |
CLV_NRD_NRD_1 | 370 | 372 | PF00675 | 0.729 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.730 |
CLV_PCSK_FUR_1 | 203 | 207 | PF00082 | 0.254 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.608 |
CLV_PCSK_KEX2_1 | 205 | 207 | PF00082 | 0.254 |
CLV_PCSK_KEX2_1 | 249 | 251 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.386 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.582 |
CLV_PCSK_KEX2_1 | 367 | 369 | PF00082 | 0.719 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.636 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.608 |
CLV_PCSK_PC1ET2_1 | 205 | 207 | PF00082 | 0.321 |
CLV_PCSK_PC1ET2_1 | 330 | 332 | PF00082 | 0.582 |
CLV_PCSK_PC1ET2_1 | 367 | 369 | PF00082 | 0.622 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.603 |
CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.605 |
CLV_PCSK_SKI1_1 | 244 | 248 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 261 | 265 | PF00082 | 0.519 |
CLV_PCSK_SKI1_1 | 367 | 371 | PF00082 | 0.632 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.671 |
DEG_SPOP_SBC_1 | 70 | 74 | PF00917 | 0.638 |
DOC_CYCLIN_RxL_1 | 17 | 28 | PF00134 | 0.607 |
DOC_MAPK_gen_1 | 18 | 24 | PF00069 | 0.622 |
DOC_MAPK_gen_1 | 209 | 218 | PF00069 | 0.521 |
DOC_MAPK_gen_1 | 281 | 290 | PF00069 | 0.516 |
DOC_MAPK_MEF2A_6 | 220 | 228 | PF00069 | 0.521 |
DOC_MAPK_MEF2A_6 | 281 | 290 | PF00069 | 0.516 |
DOC_PP1_RVXF_1 | 170 | 176 | PF00149 | 0.327 |
DOC_PP1_RVXF_1 | 18 | 25 | PF00149 | 0.617 |
DOC_PP4_FxxP_1 | 175 | 178 | PF00568 | 0.451 |
DOC_PP4_FxxP_1 | 180 | 183 | PF00568 | 0.459 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.709 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.724 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 361 | 365 | PF00917 | 0.792 |
DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.667 |
DOC_USP7_UBL2_3 | 335 | 339 | PF12436 | 0.633 |
DOC_USP7_UBL2_3 | 349 | 353 | PF12436 | 0.600 |
DOC_USP7_UBL2_3 | 363 | 367 | PF12436 | 0.731 |
DOC_USP7_UBL2_3 | 4 | 8 | PF12436 | 0.695 |
DOC_WW_Pin1_4 | 136 | 141 | PF00397 | 0.518 |
DOC_WW_Pin1_4 | 362 | 367 | PF00397 | 0.627 |
LIG_14-3-3_CanoR_1 | 172 | 176 | PF00244 | 0.333 |
LIG_14-3-3_CanoR_1 | 19 | 25 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 203 | 213 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 244 | 249 | PF00244 | 0.515 |
LIG_14-3-3_CanoR_1 | 333 | 342 | PF00244 | 0.618 |
LIG_FHA_1 | 127 | 133 | PF00498 | 0.479 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.750 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.570 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.540 |
LIG_LIR_Apic_2 | 174 | 178 | PF02991 | 0.484 |
LIG_LIR_Apic_2 | 179 | 183 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 166 | 171 | PF02991 | 0.409 |
LIG_Pex14_2 | 188 | 192 | PF04695 | 0.454 |
LIG_Pex14_2 | 310 | 314 | PF04695 | 0.424 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.414 |
LIG_SH2_CRK | 186 | 190 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 302 | 305 | PF00017 | 0.485 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.684 |
LIG_SH3_3 | 96 | 102 | PF00018 | 0.745 |
LIG_SUMO_SIM_par_1 | 224 | 230 | PF11976 | 0.479 |
LIG_TRAF2_1 | 106 | 109 | PF00917 | 0.670 |
LIG_TRAF2_1 | 95 | 98 | PF00917 | 0.633 |
MOD_CDC14_SPxK_1 | 365 | 368 | PF00782 | 0.612 |
MOD_CDK_SPK_2 | 362 | 367 | PF00069 | 0.710 |
MOD_CDK_SPxK_1 | 362 | 368 | PF00069 | 0.729 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.668 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.604 |
MOD_CK1_1 | 204 | 210 | PF00069 | 0.456 |
MOD_CK1_1 | 334 | 340 | PF00069 | 0.779 |
MOD_CK1_1 | 362 | 368 | PF00069 | 0.589 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.734 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.622 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.533 |
MOD_Cter_Amidation | 16 | 19 | PF01082 | 0.651 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.573 |
MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.647 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.335 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.687 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.699 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.582 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.630 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.678 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.549 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.475 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.675 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.675 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.749 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.667 |
MOD_N-GLC_1 | 161 | 166 | PF02516 | 0.610 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.521 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.598 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.464 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.589 |
MOD_NEK2_2 | 25 | 30 | PF00069 | 0.545 |
MOD_PIKK_1 | 314 | 320 | PF00454 | 0.470 |
MOD_PKA_1 | 20 | 26 | PF00069 | 0.601 |
MOD_PKA_1 | 329 | 335 | PF00069 | 0.694 |
MOD_PKA_1 | 367 | 373 | PF00069 | 0.693 |
MOD_PKA_1 | 66 | 72 | PF00069 | 0.650 |
MOD_PKA_2 | 158 | 164 | PF00069 | 0.643 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.162 |
MOD_PKA_2 | 367 | 373 | PF00069 | 0.709 |
MOD_PKB_1 | 242 | 250 | PF00069 | 0.507 |
MOD_PKB_1 | 77 | 85 | PF00069 | 0.504 |
MOD_Plk_1 | 25 | 31 | PF00069 | 0.580 |
MOD_Plk_2-3 | 126 | 132 | PF00069 | 0.527 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.369 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.509 |
MOD_ProDKin_1 | 136 | 142 | PF00069 | 0.524 |
MOD_ProDKin_1 | 362 | 368 | PF00069 | 0.632 |
TRG_DiLeu_BaEn_3 | 229 | 235 | PF01217 | 0.405 |
TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 186 | 189 | PF00928 | 0.454 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.454 |
TRG_ER_diArg_1 | 241 | 244 | PF00400 | 0.472 |
TRG_ER_diArg_1 | 248 | 251 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 260 | 262 | PF00400 | 0.339 |
TRG_ER_diArg_1 | 280 | 282 | PF00400 | 0.357 |
TRG_NLS_Bipartite_1 | 8 | 23 | PF00514 | 0.667 |
TRG_NLS_MonoCore_2 | 17 | 22 | PF00514 | 0.637 |
TRG_NLS_MonoCore_2 | 327 | 332 | PF00514 | 0.622 |
TRG_NLS_MonoExtC_3 | 328 | 333 | PF00514 | 0.637 |
TRG_NLS_MonoExtN_4 | 18 | 23 | PF00514 | 0.623 |
TRG_NLS_MonoExtN_4 | 328 | 334 | PF00514 | 0.644 |
TRG_NLS_MonoExtN_4 | 58 | 63 | PF00514 | 0.621 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P9B0 | Leptomonas seymouri | 58% | 91% |
A0A3Q8I7S8 | Leishmania donovani | 90% | 99% |
A0A3R7KMG8 | Trypanosoma rangeli | 48% | 90% |
A4H691 | Leishmania braziliensis | 73% | 97% |
A4HUL4 | Leishmania infantum | 90% | 99% |
C9ZVP1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 89% |
E9ANB3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 99% |